In vitro polymyxin activity against clinical multidrug-resistant fungi.

Hanane YousfiStéphane RanqueJean-Marc RolainFadi Bittar

Published in: Antimicrobial resistance and infection control (2019)

colistin could be proposed, in clinical practice, in association with other antifungals, to treat life-threatening fungal infections caused by MDR yeasts or moulds.

Keyphrases

multidrug resistant
gram negative
acinetobacter baumannii
clinical practice
drug resistant
klebsiella pneumoniae
escherichia coli
pseudomonas aeruginosa
saccharomyces cerevisiae
cell wall